← Eichor
Study identifier: NCT06212102 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

Condition: Infertility  ·  Sponsor: Bedaya Hospital

PhasePhase 2
Planned participants120
Who can joinFemale, 35 Years to 44 Years
Healthy volunteersNo

About this study

The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.

This description comes directly from the study's public registry record.

Talk to the study team

Usama M Fouda, Prof.  ·  +201095401375  ·  umfrfouda@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (2)

Cairo UniversityCairo, Cairo Governorate, EgyptRecruiting
Bedaya HospitalGiza, EgyptNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06212102